Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Cash from Operating Activities
|
Bristol-Myers Squibb Co
Cash from Operating Activities Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Operating Activities
$13.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Operating Activities
$23.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Operating Activities
$8.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Operating Activities
$13B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Cash from Operating Activities
$2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
See Also
What is Bristol-Myers Squibb Co's Cash from Operating Activities?
Cash from Operating Activities
13.7B
USD
13.7B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Cash from Operating Activities amounts to 13.7B USD.
What is Bristol-Myers Squibb Co's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
12%
12%
Over the last year, the Cash from Operating Activities growth was 12%. The average annual Cash from Operating Activities growth rates for Bristol-Myers Squibb Co have been -1% over the past three years , 17% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
